ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 165 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2017. The put-call ratio across all filers is 1.57 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $3,106,000 | -28.3% | 42,776 | -17.0% | 0.00% | 0.0% |
Q4 2021 | $4,332,000 | -9.2% | 51,522 | -2.6% | 0.00% | -33.3% |
Q3 2021 | $4,773,000 | +8.9% | 52,924 | +15.2% | 0.00% | +50.0% |
Q2 2021 | $4,382,000 | -54.1% | 45,958 | -45.2% | 0.00% | -60.0% |
Q1 2021 | $9,549,000 | -30.7% | 83,862 | -15.7% | 0.01% | -44.4% |
Q4 2020 | $13,776,000 | +89.4% | 99,513 | +12.5% | 0.01% | +80.0% |
Q3 2020 | $7,272,000 | +116.6% | 88,473 | +106.1% | 0.01% | +66.7% |
Q2 2020 | $3,358,000 | +128.0% | 42,934 | +29.5% | 0.00% | +200.0% |
Q1 2020 | $1,473,000 | +21.7% | 33,151 | +17.0% | 0.00% | 0.0% |
Q4 2019 | $1,210,000 | +22.3% | 28,333 | +22.5% | 0.00% | 0.0% |
Q3 2019 | $989,000 | -22.1% | 23,125 | +15.6% | 0.00% | 0.0% |
Q2 2019 | $1,270,000 | -5.2% | 20,006 | +3.7% | 0.00% | 0.0% |
Q1 2019 | $1,339,000 | +95.5% | 19,301 | +22.6% | 0.00% | 0.0% |
Q4 2018 | $685,000 | -55.7% | 15,744 | -22.3% | 0.00% | 0.0% |
Q3 2018 | $1,547,000 | +5.6% | 20,262 | +6.3% | 0.00% | 0.0% |
Q2 2018 | $1,465,000 | +60.8% | 19,054 | +6.7% | 0.00% | 0.0% |
Q1 2018 | $911,000 | -11.0% | 17,858 | -19.1% | 0.00% | 0.0% |
Q4 2017 | $1,024,000 | +43.0% | 22,075 | +64.1% | 0.00% | 0.0% |
Q3 2017 | $716,000 | -17.0% | 13,449 | -3.2% | 0.00% | 0.0% |
Q2 2017 | $863,000 | -61.1% | 13,888 | -57.6% | 0.00% | -66.7% |
Q1 2017 | $2,220,000 | +29.4% | 32,751 | +34.2% | 0.00% | +50.0% |
Q4 2016 | $1,715,000 | -14.3% | 24,398 | -13.5% | 0.00% | -33.3% |
Q3 2016 | $2,001,000 | +79.6% | 28,202 | +23.8% | 0.00% | +50.0% |
Q2 2016 | $1,114,000 | -42.1% | 22,781 | -25.0% | 0.00% | -33.3% |
Q1 2016 | $1,923,000 | +86.9% | 30,368 | +230.9% | 0.00% | +50.0% |
Q4 2015 | $1,029,000 | +14.0% | 9,177 | -2.1% | 0.00% | 0.0% |
Q3 2015 | $903,000 | +8.0% | 9,373 | +14.8% | 0.00% | 0.0% |
Q2 2015 | $836,000 | +89.1% | 8,163 | +14.6% | 0.00% | +100.0% |
Q1 2015 | $442,000 | – | 7,123 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
First Light Asset Management, LLC | 213,887 | $29,608,000 | 2.19% |
Rock Springs Capital Management LP | 566,500 | $78,421,000 | 1.66% |
FEDERATED HERMES, INC. | 4,280,528 | $592,554,000 | 1.21% |
AtonRa Partners | 17,646 | $2,443,000 | 1.20% |
EMERALD MUTUAL FUND ADVISERS TRUST | 218,390 | $30,232,000 | 1.05% |
EMERALD ADVISERS, LLC | 226,875 | $31,406,000 | 1.04% |
Atika Capital Management LLC | 89,000 | $12,319,000 | 0.96% |
Capital Impact Advisors, LLC | 25,582 | $3,541,000 | 0.87% |
JGP Global Gestao de Recursos Ltda. | 1,586 | $220,000 | 0.83% |
CAPITAL INTERNATIONAL LTD /CA/ | 79,742 | $11,039,000 | 0.64% |